Collegium Pharmaceutical, Inc. COLL Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s change in accrued liabilities?
- Collegium Pharmaceutical, Inc. (COLL) reported change in accrued liabilities of -$4.15M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s change in accrued liabilities changed year-over-year?
- Collegium Pharmaceutical, Inc.'s change in accrued liabilities increased by 76.5% year-over-year, from -$17.67M to -$4.15M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.